| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Donald H Gilden | |
| Gregory P Owens | |||
| Jeffrey L Bennett | |||
| Mark P Burgoon | |||
| P2860 | cites work | BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma | Q24646563 |
| A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases | Q28139227 | ||
| Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event | Q28186287 | ||
| Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion | Q28253124 | ||
| Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis | Q28284231 | ||
| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
| Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies | Q30851947 | ||
| Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response | Q30854079 | ||
| Restricted use of VH4 germline segments in an acute multiple sclerosis brain | Q32107477 | ||
| Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation | Q33784134 | ||
| Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis | Q34098936 | ||
| B cells and antibodies in CNS demyelinating disease | Q34100103 | ||
| Characterization of immune complexes in progressive rubella panencephalitis | Q34283025 | ||
| Oligoclonal bands and antibody responses in multiple sclerosis | Q34609976 | ||
| Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. | Q35168188 | ||
| Three or more routes for leukocyte migration into the central nervous system | Q35183162 | ||
| B cells in multiple sclerosis | Q35650942 | ||
| The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal | Q35702792 | ||
| Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein | Q35891689 | ||
| Regulation of plasma-cell development | Q36058417 | ||
| Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis | Q36351504 | ||
| Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction | Q36368672 | ||
| Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood | Q36602220 | ||
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
| Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs | Q37290484 | ||
| Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. | Q37385073 | ||
| A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota | Q37786871 | ||
| The T lymphocyte in experimental allergic encephalomyelitis | Q37925549 | ||
| HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody | Q39033631 | ||
| Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation | Q39692368 | ||
| Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients | Q40656580 | ||
| Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis | Q41788436 | ||
| Mumps Meningitis: Prolonged Pleocytosis and Occurrence of Mumps Virus-Specific Oligoclonal IgG in the Cerebrospinal Fluid | Q41873376 | ||
| Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV | Q42606319 | ||
| Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients | Q42619341 | ||
| Analysis of the intrathecal humoral immune response in Brown Norway (BN) rats, infected with the murine coronavirus JHM. | Q43484023 | ||
| Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma | Q44728931 | ||
| An isoelectric focusing study in herpes simplex virus encephalitis | Q44804340 | ||
| Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum | Q44960784 | ||
| Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. | Q45762642 | ||
| An isoelectric focusing overlay study of the humoral immune response in Theiler's virus demyelinating disease | Q45830882 | ||
| Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis | Q45885704 | ||
| B-lymphocyte and plasma cell clonal expansion in monosymptomatic optic neuritis cerebrospinal fluid | Q47242758 | ||
| Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis | Q47309556 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| The immunogenesis of the multiple sclerosis plaque | Q47742417 | ||
| Determinants of Human B Cell Migration Across Brain Endothelial Cells | Q48328973 | ||
| Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view | Q48400195 | ||
| Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs | Q48451211 | ||
| Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination | Q48489118 | ||
| The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion | Q48646930 | ||
| Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis | Q48949365 | ||
| The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes | Q49065980 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. | Q54759503 | ||
| Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. | Q55036043 | ||
| Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement | Q59099066 | ||
| Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis | Q59273850 | ||
| Unveiling the enigma of the CNS as a B-cell fostering environment | Q61657776 | ||
| Patterns of oligodendroglia pathology in multiple sclerosis | Q61709808 | ||
| Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis | Q66695381 | ||
| Distribution of cerebrospinal fluid oligoclonal IgM bands in neurological diseases: a comparison between agarose electrophoresis and isoelectric focusing | Q68034474 | ||
| Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown | Q70180407 | ||
| Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis | Q72630861 | ||
| Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions | Q72773066 | ||
| Pathogenesis of multiple sclerosis: the eyes only see what the mind is prepared to comprehend | Q79834864 | ||
| Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients | Q81119751 | ||
| P433 | issue | 3 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 236-244 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Neurological Research | Q15765622 |
| P1476 | title | The B cell response in multiple sclerosis | |
| P478 | volume | 28 |
| Q39960165 | A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk |
| Q34117793 | A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis |
| Q43881975 | Amelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine. |
| Q33510998 | Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient |
| Q24628925 | Atacicept: targeting B cells in multiple sclerosis |
| Q34686890 | Autophagy, inflammation and neurodegenerative disease |
| Q34808657 | B cells and multiple sclerosis |
| Q35077540 | CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis |
| Q34100842 | Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis |
| Q37111883 | DNA-based vaccines: the future of multiple sclerosis therapy? |
| Q40619934 | Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination |
| Q38083041 | Immunotherapy of multiple sclerosis: the state of the art. |
| Q64249921 | Inflammatory activity and vitamin D levels in an MS population treated with rituximab |
| Q38084075 | Intrathecal humoral immunity to encephalitic RNA viruses. |
| Q35178635 | Investigating perturbed pathway modules from gene expression data via structural equation models |
| Q36104857 | Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis |
| Q83315094 | Multiple sclerosis: current knowledge and future directions |
| Q49122634 | Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis |
| Q30842875 | Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
| Q31050845 | Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus |
| Q37445439 | Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. |
| Q34059107 | Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. |
| Q41933450 | Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis. |
| Q58096566 | Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis |
| Q48696793 | Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis. |
| Q35804573 | The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study |
| Q34193087 | The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing |
| Q35155753 | The double-edged sword of autoimmunity: lessons from multiple sclerosis |
| Q34468304 | The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. |
| Q36054757 | The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients |
| Q30354658 | Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis. |
| Q51890165 | [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis]. |
Search more.